Home/Filings/4/0001104659-24-036286
4//SEC Filing

STEFANOVICH ROBERT 4

Accession 0001104659-24-036286

CIK 0001124524other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 7:51 PM ET

Size

14.7 KB

Accession

0001104659-24-036286

Insider Transaction Report

Form 4
Period: 2024-03-09
STEFANOVICH ROBERT
CFO, Treasurer and Secretary
Transactions
  • Sale

    Common Stock

    2024-03-15$15.43/sh1,035$15,972123,662 total
  • Award

    Common Stock

    2024-03-15+5,750129,412 total
  • Exercise/Conversion

    Restricted Stock Rights

    2024-03-092,6662,667 total
    Common Stock (2,666 underlying)
  • Award

    Stock Option (right to buy)

    2024-03-15+11,50011,500 total
    Exercise: $16.70Exp: 2031-03-15Common Stock (11,500 underlying)
  • Sale

    Common Stock

    2024-03-11$16.35/sh1,119$18,298124,697 total
  • Exercise/Conversion

    Common Stock

    2024-03-09+2,666125,816 total
Footnotes (5)
  • [F1]Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
  • [F2]Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
  • [F3]Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025.
  • [F4]The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.
  • [F5]1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024.

Issuer

Cryoport, Inc.

CIK 0001124524

Entity typeother

Related Parties

1
  • filerCIK 0001247309

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:51 PM ET
Size
14.7 KB